Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 12:04 AM
NCT ID:
NCT01381458
Eligibility Criteria:
Inclusion Criteria:
* ≥40 years of age at index discharge date
* Continuous health plan eligibility in the pre-index, treatment assessment, and follow-up periods
* Absence of other fluticasone propionate -salmeterol xinafoate doses or combination product of budesonide-formoterol anytime during pre-index, treatment assessment, and follow-up periods
Exclusion Criteria:
* COPD-related exacerbation during the treatment assessment period
* Any therapy change, which was defined as switching or augmenting index therapy during treatment assessment period
* Absence of comorbid conditions (respiratory cancer, cystic fibrosis, fibrosis due to tuberculosis, bronchiectasis, pneumonociosis, pulmonary fibrosis, pulmonary tuberculosis, and sarcoidosis) during the pre-index, treatment assessment, and follow-up periods
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT01381458
Study Brief:
Protocol Section:
NCT01381458